These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6252929)

  • 1. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in hong kong: a necropsy study: 1963-1976.
    Gibson JB; Wu PC; Ho JC; Lauder IJ
    Br J Cancer; 1980 Sep; 42(3):370-7. PubMed ID: 6252929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong.
    Ho JC; Wu PC; Mak TK
    Int J Cancer; 1981 Nov; 28(5):571-4. PubMed ID: 6273339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
    Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B antigen in the liver in hepatocellular carcinoma in Shikoku, Japan.
    Akagi G; Furuya K; Otsuka H
    Cancer; 1982 Feb; 49(4):678-82. PubMed ID: 6275977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?
    Leung NW; Tam JS; Lai JY; Leung TW; Lau WY; Shiu W; Li AK
    Cancer; 1992 Jul; 70(1):40-4. PubMed ID: 1318777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells.
    Hsu HC; Lin WS; Tsai MJ
    Cancer; 1983 Nov; 52(10):1825-32. PubMed ID: 6313175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis.
    Hsu HC; Wu MZ; Chang MH; Su IJ; Chen DS
    J Hepatol; 1987 Dec; 5(3):260-7. PubMed ID: 2828461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma.
    Akagi G; Furuya K; Kanamura A; Chihara T; Otsuka H
    Cancer; 1984 Jul; 54(2):315-8. PubMed ID: 6202391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
    Yip TC; Chan HL; Wong VW; Tse YK; Lam KL; Wong GL
    J Hepatol; 2017 Nov; 67(5):902-908. PubMed ID: 28652084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autopsy study of hepatocellular carcinoma in Hong Kong.
    Ho J; Wu PC; Kung TM
    Pathology; 1981 Jul; 13(3):409-16. PubMed ID: 6272177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical investigation of hepatitis B virus-associated antigens in cases of liver cirrhosis and HBsAg antigenemia and their relationship to development of hepatocellular carcinoma.
    Iwai M; Kashiwadani M; Okuno T; Takino T; Ibata Y
    Histochem J; 1988 May; 20(5):283-9. PubMed ID: 2850288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of hepatitis B virus infection in chronic liver disease and hepatocellular carcinoma.
    de Franchis R; Primignani M; Vecchi M; Antoniozzi F; Colombo M; Colucci G; Tommasini M
    Ric Clin Lab; 1984; 14(1):81-8. PubMed ID: 6328629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orcein-positive hepatitis B surface antigen and liver carcinoma: their association in an Eastern US population.
    Keshgegian AA; Ochs RH
    Arch Pathol Lab Med; 1981 Apr; 105(4):190-3. PubMed ID: 6163416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma. A study of 50 autopsy cases with detection of hepatitis B surface antigen in fixed tissues.
    Perez-Barrios A; Colina-Ruizdelgado F; Gallego I; Martinez-Tello FJ
    Pathol Res Pract; 1983 Mar; 176(2-4):131-44. PubMed ID: 6190153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta agent and the etiology of hepatocellular carcinoma.
    Trichopoulos D; Day NE; Tzonou A; Hadziyannis S; Kaklamani E; Sparos L; Muñoz N; Hatzakis A
    Int J Cancer; 1987 Mar; 39(3):283-6. PubMed ID: 3028967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
    Tomimatsu M; Ishiguro N; Taniai M; Okuda H; Saito A; Obata H; Yamamoto M; Takasaki K; Nakano M
    Cancer; 1993 Aug; 72(3):683-8. PubMed ID: 8192727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.